Track 22: Drug Discovery and Development

Overview: Drug Discovery and Development

Drug Discovery and Development is a systematic, multidisciplinary process aimed at identifying new candidate medications and bringing them safely and effectively to patients. The process combines scientific research, clinical testing, regulatory review, and post-market monitoring to create therapies that address unmet medical needs or improve on existing treatments.

Key Sub-Topics in Drug Discovery and Development:

Target Identification and Validation · Hit-to-Lead and Lead Optimization · High-Throughput Screening · Computational Drug Design · Preclinical Safety and Toxicology · IND-Enabling Studies · Clinical Trial Design (Phase I–IV) · Regulatory Pathways (FDA, EMA) · Pharmacovigilance · Biomarkers and Companion Diagnostics · Drug Repurposing · Biologics and Biosimilars · RNA Therapeutics and mRNA Vaccines · Artificial Intelligence in Drug Discovery · Personalized Drug Development